Anti-transgender activists see this upcoming Supreme Court term as their chance to further insert religion into medicine and its regulation in the United States. On Oct. 7, the Supreme Court will hear ...

Vanbarton Group locked in a large loan from Brookfield to close a Midtown office deal, marking the developer’s latest office-to-residential play. Brookfield provided a $300 million loan to finance ...

The city's former Downtown YMCA building will be converted into an affordable housing complex called Lofts at 40 Long. The project will create 121 apartments for households earning between 30% and 80% ...

US-based airlines have been urged to re-examine their safety practices amidst a 'recurring safety hazard'. The US Department of Transportation Federal Aviation Administration issued its message in a ...

The boss of Unite, Labour's biggest union funder, has threatened to break its link with the party unless it changes direction. Sharon Graham, general secretary of the union, told Sky News that, on the ...

I found your column "Do Roth IRA conversions still make sense with the passage of the GOP tax law?" very helpful and I better understand the strategic choice a conversion to a Roth IRA represents. My ...

Catholics and all people committed to protecting the planet must keep climate action from slipping into trends or tribalism, Pope Leo XIV said as he opened a global church summit on climate change ...

Days after US President Donald Trump sounded off the alarm against pregnant women using paracetamol or acetaminophen (in the US – Tylenol and similar products), a report alleged that its maker was ...

The Institute of Banking Personnel Selection will close the registration process for IBPS RRB Recruitment 2025 on September 28, 2025. Candidates who want to apply for the posts can find the direct ...

Amazon will pay $2.5 billion to settle claims by the U.S. Federal Trade Commission (FTC) that it used dark patterns to trick millions of users into enrolling in its Prime program and made it as ...

A significant advancement in skin cancer treatment has arrived. The US FDA has approved cemiplimab, known as Libtayo, to help prevent certain skin cancers from returning after surgery and radiation.